IL2RG and breast carcinoma: Six weeks post-injection, tumors developed in all mice (100%, N = 5) with different Rag2 and Il2rγ knockout mutant alleles and a tumor was also noted in the NOD SCID gamma control mouse with a defective immune system which allows proliferation of human mammary carcinoma cells(Fig 2E and 2F, arrows).